GGrantIndex
← Leaderboards

Mahesh Mohan

Tulane University Of Louisiana

$12,801,428
Attributed
$18,731,408
Total exposure
20
Grants
16
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.7M · FY200625
$5M$3.8M$2.5M$1.3M$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$18,731,408 · 20

By mechanism

R01$16,500,460 · 6
R33$877,149 · 1
P51$620,846 · 11
R21$439,113 · 1
R56$293,840 · 1

Top collaborators

Most similar at Tulane University Of Louisiana

Same institution · by research overlap

Others in their field

Top investigators on “Inflammation

Research focus

InflammationInfectionMolecularChronicCellsMacacaPathogenesisMacaca MulattaIntestinesImmune ActivationDisease ProgressionGastrointestinal Tract StructureViralGene ExpressionMediatingAffectInflammatoryFunctional DisorderTetrahydrocannabinolLymphocyteBloodMicrornasAntiretroviral TherapyPlay

Grant awards (41)

Use of Focused ultrasound stimulated blood brain barrier opening for CNS HIV/SIV reservoir reduction$1,825,990
R01 · FY2025 · DA · contact PI
Cannabinoid inhibition of CNS inflammasome activation via modulation of the gut-brain axis$898,025
R01 · FY2025 · DA
Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection$692,889
R01 · FY2024 · DA · contact PI
Characterizing the physicochemical properties of membraneless condensates and its regulation by delta-9-tetrahydrocannabinol in HIV/SIV infection.$436,546
R33 · FY2024 · DA
Cannabinoid modulation of EV composition and function in HIV/SIV infection$784,694
R01 · FY2023 · DA
Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection$696,885
R01 · FY2023 · DA · contact PI
Characterizing the physicochemical properties of membraneless condensates and its regulation by delta-9-tetrahydrocannabinol in HIV/SIV infection.$440,603
R33 · FY2023 · DA
Cannabinoid modulation of EV composition and function in HIV/SIV infection$775,988
R01 · FY2022 · DA
Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection$700,759
R01 · FY2022 · DA · contact PI
Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection-supplement$472,498
R01 · FY2022 · DA · contact PI
Characterizing the physicochemical properties of membraneless condensates and its regulation by delta-9-tetrahydrocannabinol in HIV/SIV infection.$218,020
R21 · FY2022 · DA
Cannabinoid modulation of EV composition and function in HIV/SIV infection$745,173
R01 · FY2021 · DA
Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection$704,526
R01 · FY2021 · DA · contact PI
Characterizing the physicochemical properties of membraneless condensates and its regulation by delta-9-tetrahydrocannabinol in HIV/SIV infection.$221,093
R21 · FY2021 · DA
Role of microRNAs in B-cell dysfunction in HIV/SIV infection$942,811
R01 · FY2020 · DA · contact PI
Cannabinoid modulation of EV composition and function in HIV/SIV infection$787,400
R01 · FY2020 · DA
Epigenetic mechanisms underlying cannabinoid modulation of neuroinflammation in HIV/SIV infection$730,433
R01 · FY2020 · DA · contact PI
Role of microRNAs in B-cell dysfunction in HIV/SIV infection$815,518
R01 · FY2019 · DA · contact PI
Cannabinoid modulation of EV composition and function in HIV/SIV infection$728,439
R01 · FY2019 · DA
Role of microRNAs in B-cell dysfunction in HIV/SIV infection$825,445
R01 · FY2018 · DA · contact PI
Role of microRNAs in B-cell dysfunction in HIV/SIV infection$825,628
R01 · FY2017 · DA · contact PI
Molecular pathology of oral immune dysregulation in HIV/SIV infection$211,840
R56 · FY2017 · DE · contact PI
Molecular pathology of oral immune dysregulation in HIV/SIV infection$82,000
R56 · FY2017 · DE · contact PI
Role of microRNAs in B-cell dysfunction in HIV/SIV infection$825,628
R01 · FY2016 · DA · contact PI
Molecular Pathology of HIV/SIV Enteropathy$334,677
R01 · FY2014 · DK · contact PI
Molecular Pathology of HIV/SIV Enteropathy$278,119
R01 · FY2013 · DK · contact PI
Molecular Pathology of HIV/SIV Enteropathy$1,500
R01 · FY2013 · DK · contact PI
Molecular Pathology of HIV/SIV Enteropathy$351,075
R01 · FY2012 · DK · contact PI
Molecular Pathology of HIV/SIV Enteropathy$351,075
R01 · FY2011 · DK · contact PI
TRANSCRIPTOME PROFILING OF THE INTESTINAL LAMINA PROPRIA IN SIV INFECTION$57,750
P51 · FY2011 · RR · contact PI
MOLECULAR PATHOLOGY OF HIV/SIV ENTEROPATHY$57,750
P51 · FY2011 · RR · contact PI
CANNABINOID EPIGENOMIC AND MIRNA MECHAMISMS IMPACT HIV/SIV DISEASE PROGRESSION$57,750
P51 · FY2011 · RR · contact PI
ROLE OF MICRORNAS IN THE MOLECULAR PATHOGENESIS OF HIV/SIV ENTEROPATHY$45,154
P51 · FY2011 · RR · contact PI
Molecular Pathology of HIV/SIV Enteropathy$405,285
R01 · FY2010 · DK · contact PI
ROLE OF MICRORNAS IN THE MOLECULAR PATHOGENESIS OF HIV/SIV ENTEROPATHY$39,400
P51 · FY2010 · RR · contact PI
C/EPB BETA AIDS AND THE GASTROINTESTINAL TRACT$60,376
P51 · FY2009 · RR · contact PI
ROLE OF MICRORNAS IN THE MOLECULAR PATHOGENESIS OF HIV/SIV ENTEROPATHY$36,333
P51 · FY2009 · RR · contact PI
C/EPB BETA AIDS AND THE GASTROINTESTINAL TRACT$64,630
P51 · FY2008 · RR · contact PI
GI DYSFUNCTION IN SIV-INFECTED MACAQUES$64,630
P51 · FY2008 · RR · contact PI
TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION IN SIV INFECTED RHESUS MACAQUES$71,638
P51 · FY2007 · RR · contact PI
TRANSDUCERS AND ACTIVATORS OF TRANSCRIPTION IN SIV INFECTED RHESUS MACAQUES$65,435
P51 · FY2006 · RR · contact PI